跳至主要内容
临床试验/NCT05794698
NCT05794698招募中不适用

Concordance Between Intraoperative Frozen Section and Postoperative Pathology in Diagnosing the Subtype of Lung Adenocarcinoma and Guiding the Surgical Procedure of Lung Adenocarcinoma: a Multi-center Prospective Study

Fudan University1 个研究点 分布在 1 个国家目标入组 1,063 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,063
试验地点
1
主要终点
Concordance rate

研究概览

简要总结

This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1014). The goal of this clinical trial is to confirm the concordance rate between intra-operative frozen section pathological diagnosis and post-operative paraffin embedded pathological diagnosis, and use this result to guide surgical treatment for early stage (cT1N0M0) lung adenocarcinomas.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who sign the informed consent form and are willing to complete the study according to the study protocol;
  • No previous history of cancer or pulmonary surgery;
  • Solitary lesions or multiple lesions with only one not manifesting as pure ground-glass opacity (GGO) on CT scan;
  • Peripheral clinical T1N0M0 patients that are eligible for surgery;
  • Non-small cell lung cancer is pathologically diagnosed before or at surgery;
  • No radiation therapy or chemotherapy before surgery.

排除标准

  • Patients with clinical stages other than T1N0M0;
  • The lesion cannot be completely resected;
  • Previous history of cancer;
  • Patients having received radiation therapy or chemotherapy.

结局指标

主要结局

Concordance rate

时间窗: 2 years

Concordance rate between intraoperative frozen section and postoperative paraffin embedded pathology in making the diagnosis of lung adenocarcinoma subtypes according to the WHO classifications.

次要结局

  • Concordance rate(2 years)
  • Recurrence-free survival (RFS)(5 years)
  • Overall survival (OS)(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haiquan Chen

Professor

Fudan University

研究点 (1)

Loading locations...

相似试验